152 related articles for article (PubMed ID: 29935313)
1. Reactive oxygen species in cancer stem cells of head and neck squamous cancer.
Qian X; Nie X; Yao W; Klinghammer K; Sudhoff H; Kaufmann AM; Albers AE
Semin Cancer Biol; 2018 Dec; 53():248-257. PubMed ID: 29935313
[TBL] [Abstract][Full Text] [Related]
2. Novel C-Terminal Heat Shock Protein 90 Inhibitors (KU711 and Ku757) Are Effective in Targeting Head and Neck Squamous Cell Carcinoma Cancer Stem cells.
Subramanian C; Kovatch KJ; Sim MW; Wang G; Prince ME; Carey TE; Davis R; Blagg BSJ; Cohen MS
Neoplasia; 2017 Dec; 19(12):1003-1011. PubMed ID: 29121598
[TBL] [Abstract][Full Text] [Related]
3. Distinct roles of PIK3CA in the enrichment and maintenance of cancer stem cells in head and neck squamous cell carcinoma.
Chen X; Cao Y; Sedhom W; Lu L; Liu Y; Wang H; Oka M; Bornstein S; Said S; Song J; Lu SL
Mol Oncol; 2020 Jan; 14(1):139-158. PubMed ID: 31600013
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological inhibition of HDAC6 overcomes cisplatin chemoresistance by targeting cancer stem cells in oral squamous cell carcinoma.
Tavares MO; Milan TM; Bighetti-Trevisan RL; Leopoldino AM; de Almeida LO
J Oral Pathol Med; 2022 Jul; 51(6):529-537. PubMed ID: 35678235
[TBL] [Abstract][Full Text] [Related]
5. Distinct subpopulations of head and neck cancer cells with different levels of intracellular reactive oxygen species exhibit diverse stemness, proliferation, and chemosensitivity.
Chang CW; Chen YS; Chou SH; Han CL; Chen YJ; Yang CC; Huang CY; Lo JF
Cancer Res; 2014 Nov; 74(21):6291-305. PubMed ID: 25217518
[TBL] [Abstract][Full Text] [Related]
6. C-Met pathway promotes self-renewal and tumorigenecity of head and neck squamous cell carcinoma stem-like cell.
Lim YC; Kang HJ; Moon JH
Oral Oncol; 2014 Jul; 50(7):633-9. PubMed ID: 24835851
[TBL] [Abstract][Full Text] [Related]
7. Epithelial-to-mesenchymal transition and cancer stem(-like) cells in head and neck squamous cell carcinoma.
Chen C; Zimmermann M; Tinhofer I; Kaufmann AM; Albers AE
Cancer Lett; 2013 Sep; 338(1):47-56. PubMed ID: 22771535
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic modifications control loss of adhesion and aggressiveness of cancer stem cells derived from head and neck squamous cell carcinoma with intrinsic resistance to cisplatin.
Milan TM; Eskenazi APE; Bighetti-Trevisan RL; de Almeida LO
Arch Oral Biol; 2022 Sep; 141():105468. PubMed ID: 35679799
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of Head and Neck Squamous Cell Carcinoma Stem Cells.
Qian X; Nie X; Wollenberg B; Sudhoff H; Kaufmann AM; Albers AE
Adv Exp Med Biol; 2019; 1139():23-40. PubMed ID: 31134493
[TBL] [Abstract][Full Text] [Related]
10. Anti-cancer effects of disulfiram in head and neck squamous cell carcinoma via autophagic cell death.
Park YM; Go YY; Shin SH; Cho JG; Woo JS; Song JJ
PLoS One; 2018; 13(9):e0203069. PubMed ID: 30212479
[TBL] [Abstract][Full Text] [Related]
11. Epithelial-mesenchymal transition and cancer stem cells: A route to acquired cisplatin resistance through epigenetics in HNSCC.
Lima de Oliveira J; Moré Milan T; Longo Bighetti-Trevisan R; Fernandes RR; Machado Leopoldino A; Oliveira de Almeida L
Oral Dis; 2023 Jul; 29(5):1991-2005. PubMed ID: 35403781
[TBL] [Abstract][Full Text] [Related]
12. Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells.
Bourguignon LYW; Earle C; Shiina M
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837080
[TBL] [Abstract][Full Text] [Related]
13. Cancer stem cell biomarkers for head and neck squamous cell carcinoma: A bioinformatic analysis.
Xiao M; Liu L; Zhang S; Yang X; Wang Y
Oncol Rep; 2018 Dec; 40(6):3843-3851. PubMed ID: 30542719
[TBL] [Abstract][Full Text] [Related]
14. Cancer stem cells in head and neck squamous cell carcinoma: a review.
Satpute PS; Hazarey V; Ahmed R; Yadav L
Asian Pac J Cancer Prev; 2013; 14(10):5579-87. PubMed ID: 24289547
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of Cisplatin Resistance in HPV Negative Head and Neck Squamous Cell Carcinomas.
Griso AB; Acero-Riaguas L; Castelo B; Cebrián-Carretero JL; Sastre-Perona A
Cells; 2022 Feb; 11(3):. PubMed ID: 35159370
[TBL] [Abstract][Full Text] [Related]
16. [Cancer stem cell phenotypes and miRNA: therapeutic targets in head and neck squamous cell carcinoma].
Coordes A; Zhifeng S; Sangvatanakul V; Qian X; Lenarz M; Kaufmann AM; Albers AE
HNO; 2014 Dec; 62(12):867-72. PubMed ID: 25337967
[TBL] [Abstract][Full Text] [Related]
17. Progress and pitfalls in the identification of cancer stem cell-targeting therapies in head and neck squamous cell carcinoma.
Kiang A; Yu MA; Ongkeko WM
Curr Med Chem; 2012; 19(35):6056-64. PubMed ID: 22963569
[TBL] [Abstract][Full Text] [Related]
18. Liposome encapsulated curcumin-difluorinated (CDF) inhibits the growth of cisplatin resistant head and neck cancer stem cells.
Basak SK; Zinabadi A; Wu AW; Venkatesan N; Duarte VM; Kang JJ; Dalgard CL; Srivastava M; Sarkar FH; Wang MB; Srivatsan ES
Oncotarget; 2015 Jul; 6(21):18504-17. PubMed ID: 26098778
[TBL] [Abstract][Full Text] [Related]
19. Regulation of tumor progression via the Snail-RKIP signaling pathway by nicotine exposure in head and neck squamous cell carcinoma.
Nieh S; Jao SW; Yang CY; Lin YS; Tseng YH; Liu CL; Lee TY; Liu TY; Chu YH; Chen SF
Head Neck; 2015 Dec; 37(12):1712-21. PubMed ID: 24986226
[TBL] [Abstract][Full Text] [Related]
20. Metformin Results in Diametrically Opposed Effects by Targeting Non-Stem Cancer Cells but Protecting Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma.
Kuo SZ; Honda CO; Li WT; Honda TK; Kim E; Altuna X; Abhold E; Wang-Rodriguez J; Ongkeko WM
Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30621095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]